Protein profile

PA2535

oxidoreductase

Genome: NC_002516.2

Gene: PA2535 Structure source: AlphaFold UniProt Q9I0U9
Amino acids 331
Annotations 2
Features 9
PDB binders 6
Druggability 0.737

Overview

Basic information about this protein and its source genome.

Accession
PA2535
Gene
PA2535
Status
annotated
Amino acids
331
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
32.632
Human E-value
9.99e-06
Gut microbiome off-target
hit
Essential (DEG)
N
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.737
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

2 GO

Gene Ontology (GO)

2
  • GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.

Sequence Features

Domain/signature hits from InterPro and related databases.

9 records
Show feature table
Start End DB Term Name
1 20 ProSiteProfiles PS51257 Prokaryotic membrane lipoprotein lipid attachment site profile.
4 322 PANTHER PTHR43625 AFLATOXIN B1 ALDEHYDE REDUCTASE
2 307 CDD cd19076 AKR_AKR13A_13D
1 312 SUPERFAMILY SSF51430 NAD(P)-linked oxidoreductase
1 312 InterPro IPR036812 NADP-dependent oxidoreductase domain superfamily
1 329 Gene3D G3DSA:3.20.20.100 -
1 329 InterPro IPR036812 NADP-dependent oxidoreductase domain superfamily
16 310 Pfam PF00248 Aldo/keto reductase family
16 310 InterPro IPR023210 NADP-dependent oxidoreductase domain

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA2535
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.737

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

56 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
ATR Q3L181 507.2 Da LogP -1.63 TPSA 279.1 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
CAC Q8ZNA1 137.0 Da LogP -0.52 TPSA 40.1 ✓ Ro5 ✓ Clean C[As](=O)(C)[O-]
EPR Q9X265 319.4 Da LogP 2.92 TPSA 57.6 ✓ Ro5 Alert C/C(=C\c1ccccc1)/C=C2C(=O)N(C(=S)S2)CC(=O)O
FLC Q46851 189.1 Da LogP -5.25 TPSA 140.6 ✓ Ro5 ✓ Clean C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
PDN P62483 358.4 Da LogP 3.16 TPSA 94.8 ✓ Ro5 ✓ Clean C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=CO)…
TOL Q9X265 357.4 Da LogP 3.56 TPSA 49.8 ✓ Ro5 ✓ Clean CN(CC(=O)O)C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.